The Australian small-cap market was little changed on Monday morning as investors weighed stronger-than-expected US employment growth, higher interest-rate expectations and escalating tensions in the Middle East.
At market open, the S&P/ASX Small Ordinaries was down 0.8 points, or 0.02%, at 3,470.80. The index opened at 3,471.60 and traded within a narrow early range of 3,470.60 to 3,471.60.
The XSO remained around 0.3% higher over five trading days after recovering from a midweek low near 3,425. It reached 3,478.90 on Friday before easing into Monday’s session.
At its latest level, the index was about 13.4% below its 52-week high of 4,007.10 and 9% above its 52-week low of 3,184.50.
The subdued start followed a weaker lead from Wall Street after strong US payrolls increased expectations of a Federal Reserve rate rise in September. Higher oil prices provided some support for energy companies, while lower gold prices presented a headwind for junior precious-metals stocks.
Against this cautious market backdrop, Tamboran Resources achieved first gas sales from the Beetaloo Basin, while Anteris Technologies appointed an experienced medical technology executive as chief financial officer.
Tamboran begins first Beetaloo gas sales
Tamboran Resources Corporation (NYSE:TBN, ASX:TBN, OTC:TBNRL, FRA:O8R) and Daly Waters Energy LP have commenced initial gas sales from the Shenandoah South Pilot Project in the Northern Territory.
The milestone represents the first gas volumes delivered from the Beetaloo Basin into the Northern Territory market.
Production is expected to ramp up to the full contracted rate of 40 terajoules per day by early 2027.
The gas is covered by a long-term take-or-pay agreement with the Northern Territory Government, providing a contracted market as production increases.
Tamboran and Daly Waters Energy will receive a discounted price during commissioning, reflecting the interruptible nature of supply while the project ramps up.
The achievement follows the recent start of commissioning at the Sturt Plateau Compression Facility using gas from the Shenandoah South 2 well pad.
Anteris Technologies appoints new finance chief
Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has appointed Brent Moen as chief financial officer, effective September 12, 2026.
Moen has more than 25 years of financial leadership experience across public and private companies, including medical technology businesses.
His expertise includes capital markets, investor relations, mergers and acquisitions and scaling growth-focused organisations.
Moen previously served as chief financial officer of LifeLens Technologies, Tactile Systems Technology and Entellus Medical.
Matthew McDonnell will step down as chief financial officer and transition to the role of head of Australia when Moen’s appointment takes effect.